// App-Quantinova.ai

1123-369 : THE RELEVANCE TO CLINICAL OUTCOMES AND RISK FACTORS OF PERI-CONTRAST STAINING (PSS) AFTER SECOND GENERATION DES DEPLOYMENT

Researchers

Presenter

  • Takahiro Tokuda

Principal Investigators

  • Toshiya Muramatsu

  • Reiko Tsukahara

  • Yoshiaki Ito

  • Hiroshi Ishimori

  • Keisuke Hirano

  • Masatsugu Nakano

  • Masahiro Yamawaki

  • Motoharu Araki

  • Norihiro Kobayashi

  • Hideyuki Takimura

Medical Centers

  • Saiseikai Yokohama-city Eastern Hospital, Yokohama, kanagawa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved